Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes
https://doi.org/10.14341/DM7622
Abstract
In recent years, actively studied the effect of androgen deficiency on the cardiovascular system, including endothelial function. Genomic effects of testosterone caused by the length of CAG repeats polymorphism in the androgen receptor (AR) gene.
Aim.
To examine the association of the polymorphism in the AR gene and carbohydrate, lipid metabolism, endothelial function in men with type 2 diabetes.
Materials and methods.
We examined 88 men, aged 40-65 years (mean age 53±6,4years) with type 2 diabetes. All patients underwent the study of carbohydrate and lipid metabolism, the assessment of vasomotor endothelial function of the brachial artery by ultrasound sonography, were studied biochemical markers of endothelial dysfunction – ICAM-1, VCAM-1, p-selectin, e-selectin, resistin and number of CAG-repeats in the AR gene. Statistical analysis was performed using the application package SPSS 21,0 using regression analysis.
Results.
The number of CAG repeats had a significant positive regression to the level of total testosterone, a weak negative regression of the number of CAG repeats in the AR gene and lipid metabolism: triglycerides, LDL, atherogenic index. The assessment of the brachial artery ultrasonography revealed negative regression of the baseline brachial artery diameter and blood flow velocity in the endothelium-dependent vasodilation. The number of CAG repeats was significantly correlated with the levels of p-selectin and resistin. Thus, increasing the number of CAG repeats in the AR gene via a weakening of sensitivity to androgens leads to disruption of endothelial function in men with type 2 diabetes. Increasing the number of CAG repeats in the AR gene leads to deterioration of linear flow velocity during the test with reactive hyperemia with increasing production of p-selectin and resistin.
Conclusions.
The number of CAG repeats in the AR gene can be regarded as a predictor of the development and progression of cardiovascular lesions in men with type 2 diabetes.
Keywords
About the Authors
Irina Alekseevna KhripunRussian Federation
MD, PhD, Assistance professor
Competing Interests:
Авторы статьи заявляют об отсутствии финансовой заинтересованности и других потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Sergey Vladislavovich Vorobyev
Russian Federation
MD, PhD, Professor
Competing Interests:
Авторы статьи заявляют об отсутствии финансовой заинтересованности и других потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Michael Iosifovich Kogan
Russian Federation
MD, PhD, Professor
Competing Interests:
Авторы статьи заявляют об отсутствии финансовой заинтересованности и других потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
References
1. Kelly DM, Jones TH. Testosterone and cardiovascular risk in men. Frontiers of hormone research. 2014;43:1-20. doi: 10.1159/000360553
2. Muraleedharan V, Jones TH. Testosterone and mortality. Clinical endocrinology. 2014;81(4):477-487. doi: 10.1111/cen.12503
3. Channer KS. Endogenous testosterone levels and cardiovascular disease in healthy men. Heart. 2011;97(11):867-869. doi: 10.1136/hrt.2010.217414
4. Akishita M, Hashimoto M, Ohike Y, et al. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertension research. 2007;30(11):1029-1034. doi: 10.1291/hypres.30.1029.
5. Хрипун И.А., Гусова З.Р., Ибишев Х.С., и др. Эндотелиальная дисфункция у мужчин: взгляд клинициста. // Бюллетень сибирской медицины. – 2014. – Т. 13. – №5 – С.169-178. [Khripun IA, Gusova ZR, Ibishev HS, et al. Endotelialnaya dysfunczia u muzhin: vzglyad clinizista. Bulleten’ sibirskoy medicini. 2014;13(5):169-178. (in Russ).]
6. Stanworth RD, Kapoor D, Channer KS, Jones TH. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clinical endocrinology. 2011;74(5):624-630. doi: 10.1111/j.1365-2265.2011.03969.x
7. Grassetti D, Giannandrea F, Paoli D, et al. Androgen receptor polymorphisms and testicular cancer risk. Andrology. 2015;3(1):27-33. doi: 10.1111/j.2047-2927.2014.00252.x
8. Sun JH, Lee SA. Association between CAG repeat polymorphisms and the risk of prostate cancer: a meta-analysis by race, study design and the number of (CAG)n repeat polymorphisms. International journal of molecular medicine. 2013;32(5):1195-1203. doi: 10.3892/ijmm.2013.1474
9. Delli Muti N, Tirabassi G, Buldreghini E, et al. Synergistic effect of androgen receptor (CAG repeat length) and endothelial nitric oxide synthase (Glu298Asp variant) gene polymorphisms on seminal parameters in men with idiopathic oligoasthenozoospermia. Endocrine. 2014;47(1):322-324. doi: 10.1007/s12020-014-0193-2
10. Коган М.И., Киреев А.Ю. Различия уровней тестостерона и полиморфизма андрогенового рецептора у пациентов с симптомной доброкачественной гиперплазией простаты в зависимости от сексуальной активности // Андрология и генитальная хирургия. – 2009. – №2 – С.118. [Kogan MI, Kireev AU. Razlichia urovney testosterona i polimorphizma androgenovogo rezeptorau pazientov s simptomnoy dobrokachestvennoy hyperplasieyprostati v zavisimosti ot seksualnoy aktivnosti. Andrologia i genitalnaya hirurgia. 2009;(2):118. (in Russ).]
11. Zitzmann M, Brune M, Kornmann B, et al. The CAG Repeat Polymorphism in the AR Gene Affects High Density Lipoprotein Cholesterol and Arterial Vasoreactivity. The Journal of Clinical Endocrinology & Metabolism. 2001;86(10):4867-4873. doi: doi:10.1210/jcem.86.10.7889
12. van Sloten TT, Henry RM, Dekker JM, et al. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension. 2014;64(6):1299-1305. doi: 10.1161/HYPERTENSIONAHA.114.04221
13. Дедов И.И., Шестакова М.В. Сахарный диабет и артериальная гипертензия. – М.: МИА;2006. [Dedov II, Shestakova MV. Saharniy diabet i arterialnaya gipertenzia. Moscow: MIA; 2006. (in Russ).]
14. Goutou M, Sakka C, Stakias N, et al. AR CAG repeat length is not associated with serum gonadal steroids and lipid levels in healthy men. International journal of andrology. 2009;32(6):616-622. doi: 10.1111/j.1365-2605.2008.00908.x
15. Huhtaniemi IT, Pye SR, Limer KL, et al. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. The Journal of clinical endocrinology and metabolism. 2009;94(1):277-284. doi: 10.1210/jc.2008-0848
16. Toke J, Czirjak G, Bezzegh A, et al. Effects and significance of estradiol in men. Orvosi hetilap. 2014;155(23):891-896. doi: 10.1556/OH.2014.29914
17. McGrath KC, Hill MD, McRobb LS, Heather AK. The androgen receptor drives the sex-specific expression of vascular cell adhesion molecule-1 in endothelial cells but not lipid metabolism genes in monocyte-derived macrophages. Hormone molecular biology and clinical investigation. 2010;2(1):203-209. doi: 10.1515/HMBCI.2010.022
18. Zhang X, Wang L, Dou Y, et al. Testosterone and estradiol modulate TNF-alpha-induced expression of adhesion molecules in endothelial cells. Methods and findings in experimental and clinical pharmacology. 2002;24(3):125-130. doi: 10.1358/mf.2002.24.3.802295
Supplementary files
Review
For citations:
Khripun I.A., Vorobyev S.V., Kogan M.I. Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes. Diabetes mellitus. 2015;18(4):35-40. (In Russ.) https://doi.org/10.14341/DM7622

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).